Olga Milo

1.8k total citations
29 papers, 1.3k citations indexed

About

Olga Milo is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Olga Milo has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Olga Milo's work include Heart Failure Treatment and Management (19 papers), Cardiovascular Function and Risk Factors (10 papers) and Hemodynamic Monitoring and Therapy (7 papers). Olga Milo is often cited by papers focused on Heart Failure Treatment and Management (19 papers), Cardiovascular Function and Risk Factors (10 papers) and Hemodynamic Monitoring and Therapy (7 papers). Olga Milo collaborates with scholars based in United States, Israel and Netherlands. Olga Milo's co-authors include Gad Cotter, Zvi Vered, Edo Kaluski, Irit Dinur, Abraham Rudnick, Eyal Shemesh, Marco Metra, Beth A. Davison, Yaron Moshkovitz and Rikardo Krakover and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

Olga Milo

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olga Milo United States	18	980	333	220	167	136	29	1.3k
Alex Blatt Israel	14	866 0.9×	327 1.0×	294 1.3×	250 1.5×	258 1.9×	33	1.4k
Stuart Zarich United States	24	1.4k 1.4×	758 2.3×	388 1.8×	84 0.5×	138 1.0×	90	2.1k
Theresa A. McDonagh United Kingdom	24	1.8k 1.8×	329 1.0×	387 1.8×	134 0.8×	90 0.7×	48	2.4k
Olga Milo‐Cotter United States	18	743 0.8×	159 0.5×	267 1.2×	132 0.8×	111 0.8×	26	987
Bernhard Frey Switzerland	25	903 0.9×	393 1.2×	444 2.0×	232 1.4×	149 1.1×	82	1.9k
Diederik van Dijk Netherlands	20	572 0.6×	693 2.1×	221 1.0×	310 1.9×	145 1.1×	53	1.6k
Łukasz J. Krzych Poland	21	563 0.6×	411 1.2×	227 1.0×	82 0.5×	156 1.1×	181	1.6k
Omar Farouque Australia	25	1.2k 1.2×	531 1.6×	131 0.6×	106 0.6×	112 0.8×	147	1.8k
Sahil Agrawal United States	19	605 0.6×	411 1.2×	135 0.6×	280 1.7×	242 1.8×	63	1.1k
Dennis R. Bresnahan United States	18	1.9k 1.9×	605 1.8×	250 1.1×	176 1.1×	76 0.6×	26	2.4k

Countries citing papers authored by Olga Milo

Since Specialization

Citations

This map shows the geographic impact of Olga Milo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Milo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Milo more than expected).

Fields of papers citing papers by Olga Milo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Milo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Milo. The network helps show where Olga Milo may publish in the future.

Co-authorship network of co-authors of Olga Milo

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Milo. A scholar is included among the top collaborators of Olga Milo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Milo. Olga Milo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cotter, Gad, Marco Metra, Beth A. Davison, et al.. (2017). Systolic Blood Pressure Reduction During the First 24 H in Acute Heart Failure Admission: Friend or Foe?. European Journal of Heart Failure. 20(2). 317–322. 17 indexed citations

Cleland, John G.F., John R. Teerlink, Beth A. Davison, et al.. (2017). Measurement of Troponin and Natriuretic Peptides Shortly After Admission in Patients with Heart Failure—Does it Add Useful Prognostic Information? an Analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute Heart Failure Studies (VERITAS). European Journal of Heart Failure. 19(6). 739–747. 24 indexed citations

Sliwa, Karen, Albertino Damasceno, Beth A. Davison, et al.. (2016). Bi Treatment with Hydralazine/Nitrates vs. Placebo in Africans Admitted with Acute HEart Failure (BA-HEF). European Journal of Heart Failure. 18(10). 1248–1258. 6 indexed citations

Davison, Beth A., Marco Metra, Stefanie Senger, et al.. (2016). Patient Journey After Admission for Acute Heart Failure: Length Of Stay, 30-Day Readmission and 90-Day Mortality. European Journal of Heart Failure. 18(8). 1041–1050. 52 indexed citations

Cotter, Gad, Adriaan A. Voors, Margaret F. Prescott, et al.. (2015). Growth Differentiation Factor 15 (GDF-15) in Patients Admitted for Acute Heart Failure: Results from the RELAX-AHF Study. European Journal of Heart Failure. 17(11). 1133–1143. 88 indexed citations

Mentz, Robert J., Marco Metra, Gad Cotter, et al.. (2015). Early vs. Late Worsening Heart Failure During Acute Heart Failure Hospitalization: Insights from the PROTECT Trial. European Journal of Heart Failure. 17(7). 697–706. 20 indexed citations

Metra, Marco, Gad Cotter, Jill El-Khorazaty, et al.. (2015). Acute Heart Failure in the Elderly: Differences in Clinical Characteristics, Outcomes, and Prognostic Factors in the VERITAS Study. Journal of Cardiac Failure. 21(3). 179–188. 62 indexed citations

Cotter, Gad, Marco Metra, Beth A. Davison, et al.. (2014). Worsening Heart Failure, a Critical Event During Hospital Admission for Acute Heart Failure: Results from the VERITAS Study. European Journal of Heart Failure. 16(12). 1362–1371. 23 indexed citations

Cotter, Gad, Olga Milo, & Beth A. Davison. (2013). Increased Mortality after an Acute Heart Failure Episode: New Pathophysiological Insights from the RELAX-AHF Study and Beyond. Current Heart Failure Reports. 11(1). 19–30. 13 indexed citations

10.

Ponikowski, Piotr, Veselin Mitrović, Mikhail Ruda, et al.. (2013). A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure. European Heart Journal. 35(7). 431–441. 92 indexed citations

11.

Uriel, Nir, Guillermo Torre‐Amione, Olga Milo, et al.. (2005). Echocardiographic Ejection Fraction in Patients with Acute Heart Failure: Correlations with Hemodynamic, Clinical, and Neurohormonal Measures and Short-Term Outcome. European Journal of Heart Failure. 7(5). 815–819. 22 indexed citations

12.

Kaluski, Edo, Olga Milo, Nir Uriel, Zvi Vered, & Gad Cotter. (2005). Nitric Oxide Synthase Inhibitors in Refractory Cardiogenic Shock due to Myocardial Infarction after Percutaneous Coronary Intervention. 5(3). 161–167. 1 indexed citations

13.

Cotter, Gad, Edo Kaluski, Christoph Richter, et al.. (2004). 1126-117 Whole-body electrical bioimpendance is accurate in noninvasive determination of cardiac output: A thermodilution controlled, prospective, double-blind evaluation. Journal of the American College of Cardiology. 43(5). A209–A209. 2 indexed citations

14.

Shemesh, Eyal, Rachel Yehuda, Olga Milo, et al.. (2004). Posttraumatic Stress, Nonadherence, and Adverse Outcome in Survivors of a Myocardial Infarction. Psychosomatic Medicine. 66(4). 521–526. 182 indexed citations

15.

Cotter, Gad, Eyal Shemesh, Irit Dinur, et al.. (2004). Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?. American Heart Journal. 147(2). 293–300. 121 indexed citations

16.

Moshkovitz, Yaron, Edo Kaluski, Olga Milo, Zvi Vered, & Gad Cotter. (2004). Recent developments in cardiac output determination by bioimpedance: comparison with invasive cardiac output and potential cardiovascular applications. Current Opinion in Cardiology. 19(3). 229–237. 70 indexed citations

17.

Kaluski, Edo, Isaac Kobrin, Reuven Zimlichman, et al.. (2003). RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist)for the treatment of pulmonary edema. Journal of the American College of Cardiology. 41(2). 204–210. 98 indexed citations

18.

Milo, Olga, Gad Cotter, Edo Kaluski, et al.. (2003). Comparison of inflammatory and neurohormonal activation in cardiogenic pulmonary edema secondary to ischemic versus nonischemic causes. The American Journal of Cardiology. 92(2). 222–226. 81 indexed citations

19.

Cotter, Gad, Yaron Moshkovitz, Edo Kaluski, et al.. (2003). The Role of Cardiac Power and Systemic Vascular Resistance in the Pathophysiology and Diagnosis of Patients with Acute Congestive Heart Failure. European Journal of Heart Failure. 5(4). 443–451. 113 indexed citations

20.

Cotter, Gad, Christopher P. Cannon, Carolyn H. McCabe, et al.. (2003). Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study. American Heart Journal. 145(4). 622–627. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact